| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
9 |
| issn |
1687-8469
1687-8450 |
| pageRange |
937305-9 |
| publicationName |
Journal of Oncology |
| startingPage |
937305 |
| bibliographicCitation |
Marshall JL. Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism? Journal of Oncology. 2009;2009():1–9. doi: 10.1155/2009/937305. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78f026959f4bbaf0baf40969995d3f3d |
| date |
2009 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC2792961
https://pubmed.ncbi.nlm.nih.gov/20016807
https://doi.org/10.1155/2009/937305 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1687-8450
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35709
https://portal.issn.org/resource/ISSN/1687-8469 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 |